354 related articles for article (PubMed ID: 33077733)
1. Development of synthetic lethality in cancer: molecular and cellular classification.
Li S; Topatana W; Juengpanich S; Cao J; Hu J; Zhang B; Ma D; Cai X; Chen M
Signal Transduct Target Ther; 2020 Oct; 5(1):241. PubMed ID: 33077733
[TBL] [Abstract][Full Text] [Related]
2. The power and the promise of synthetic lethality for clinical application in cancer treatment.
Liu QW; Yang ZW; Tang QH; Wang WE; Chu DS; Ji JF; Fan QY; Jiang H; Yang QX; Zhang H; Liu XY; Xu XS; Wang XF; Liu JB; Fu D; Tao K; Yu H
Biomed Pharmacother; 2024 Mar; 172():116288. PubMed ID: 38377739
[TBL] [Abstract][Full Text] [Related]
3. Embracing synthetic lethality of novel anticancer therapies.
Kamal A; Shaik TB; Malik MS
Expert Opin Drug Discov; 2015 Oct; 10(10):1119-32. PubMed ID: 26211783
[TBL] [Abstract][Full Text] [Related]
4. Synthetic lethal vulnerabilities of cancer.
Fece de la Cruz F; Gapp BV; Nijman SM
Annu Rev Pharmacol Toxicol; 2015; 55():513-31. PubMed ID: 25340932
[TBL] [Abstract][Full Text] [Related]
5. [Synthetic lethality as a functional tool in basic research and in anticancer therapy].
Toma M; Skorski T; Sliwiński T
Postepy Hig Med Dosw (Online); 2014 Sep; 68():1091-103. PubMed ID: 25228518
[TBL] [Abstract][Full Text] [Related]
6. Synthetic Lethal Interactions in Cancer Therapy.
Geng X; Wang X; Zhu D; Ying S
Curr Cancer Drug Targets; 2017; 17(4):304-310. PubMed ID: 27113746
[TBL] [Abstract][Full Text] [Related]
7. Application of the concept synthetic lethality toward anticancer therapy: a promise fulfilled?
Canaani D
Cancer Lett; 2014 Sep; 352(1):59-65. PubMed ID: 23962561
[TBL] [Abstract][Full Text] [Related]
8. Advances in synthetic lethality for cancer therapy: cellular mechanism and clinical translation.
Topatana W; Juengpanich S; Li S; Cao J; Hu J; Lee J; Suliyanto K; Ma D; Zhang B; Chen M; Cai X
J Hematol Oncol; 2020 Sep; 13(1):118. PubMed ID: 32883316
[TBL] [Abstract][Full Text] [Related]
9. A Road Map to Personalizing Targeted Cancer Therapies Using Synthetic Lethality.
Parameswaran S; Kundapur D; Vizeacoumar FS; Freywald A; Uppalapati M; Vizeacoumar FJ
Trends Cancer; 2019 Jan; 5(1):11-29. PubMed ID: 30616753
[TBL] [Abstract][Full Text] [Related]
10. The role of drug-metabolizing enzymes in synthetic lethality of cancer.
Zeng Z; Zheng W; Hou P
Pharmacol Ther; 2022 Dec; 240():108219. PubMed ID: 35636517
[TBL] [Abstract][Full Text] [Related]
11. Synthetic lethality as an engine for cancer drug target discovery.
Huang A; Garraway LA; Ashworth A; Weber B
Nat Rev Drug Discov; 2020 Jan; 19(1):23-38. PubMed ID: 31712683
[TBL] [Abstract][Full Text] [Related]
12. Synthetic lethality and cancer.
O'Neil NJ; Bailey ML; Hieter P
Nat Rev Genet; 2017 Oct; 18(10):613-623. PubMed ID: 28649135
[TBL] [Abstract][Full Text] [Related]
13. Systematic analysis of cancer-specific synthetic lethal interactions provides insight into personalized anticancer therapy.
Guo L; Dou Y; Xiang Y; Luo L; Xu X; Wang Q; Zhang Y; Liang T
FEBS J; 2023 Mar; 290(6):1531-1548. PubMed ID: 36181326
[TBL] [Abstract][Full Text] [Related]
14. Harnessing synthetic lethal interactions in anticancer drug discovery.
Chan DA; Giaccia AJ
Nat Rev Drug Discov; 2011 May; 10(5):351-64. PubMed ID: 21532565
[TBL] [Abstract][Full Text] [Related]
15. Searching for synthetic lethality in cancer.
Brough R; Frankum JR; Costa-Cabral S; Lord CJ; Ashworth A
Curr Opin Genet Dev; 2011 Feb; 21(1):34-41. PubMed ID: 21255997
[TBL] [Abstract][Full Text] [Related]
16. [Development of antituberculous drugs: current status and future prospects].
Tomioka H; Namba K
Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
[TBL] [Abstract][Full Text] [Related]
17. Synthetic lethality: A promising therapeutic strategy for hepatocellular carcinoma.
Tang L; Chen R; Xu X
Cancer Lett; 2020 Apr; 476():120-128. PubMed ID: 32070778
[TBL] [Abstract][Full Text] [Related]
18. Synthetic lethality on drug discovery: an update on cancer therapy.
Yar MS; Haider K; Gohel V; Siddiqui NA; Kamal A
Expert Opin Drug Discov; 2020 Jul; 15(7):823-832. PubMed ID: 32228106
[TBL] [Abstract][Full Text] [Related]
19. Mapping genetic interactions in cancer: a road to rational combination therapies.
Tutuncuoglu B; Krogan NJ
Genome Med; 2019 Oct; 11(1):62. PubMed ID: 31640753
[TBL] [Abstract][Full Text] [Related]
20. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]